Table 1: Clinical and functional characteristics of the patients.

n or median [25th – 75th percentile]
N patients 50
Sex ratio, F/M 27/23
Age, years 67 [50; 72]
BMI 26.9 [23.9; 32.4]
Underlying disease
asthma 15
COPD 26
bronchiectasis 6
sarcoidosis 2
interstitial disease 1
Tobacco history
current-smoker, n 9
ex-smoker, n 20
never-smoker, n 21
pack-years 33 [19; 50]
MRC score 2.0 [1.0; 3.0]
Lung function
FEV1, L 1.72 [1.27; 2.12]
FEV1, % predicted 59 [53; 65]
FEV1, Z-score -2.53 [-2.96; -2.12]
FVC, L 2.22 [1.64; 2.79]
FVC, % predicted 63 [54; 67]
FVC, Z-score -2.55 [-2.88; -2.20]
Slow inspiratory VC, L 2.22 [1.61; 2.80]
FEV1/FVC 0.74 [0.70; 0.78]
FEV1/FVC, % predicted 94 [90; 98]
FEV1/FVC, Z-score -0.68 [-0.98; -0.18]
IC, L 1.62 [1.20; 2.20]
TLC, L 4.93 [4.16; 6.37]
TLC, % predicted 90 [85; 95]
FRC, L 3.31 [2.89; 4.28]
FRC, % predicted 110 [99; 131]
RV, L 2.80 [2.13; 3.40]
RV, % predicted 132 [117; 154]
RV/TLC 0.55 [0.49; 0.64]
RV/TLC, % predicted 142 [132; 152]
sRaw, kPa.s 1.63 [1.15; 2.26]
Raw, kPa.s/L 0.41 [0.30; 0.52]
Impulse Oscillometry
Zrs5Hz, kPa.s/L 0.48 [0.40; 0.63]
Zrs5Hz, % predicted 147 [128; 175]
Rrs5Hz, kPa.s/L 0.42 [0.34; 0.51]
Rrs5Hz, % predicted 134 [121; 167]
Xrs5Hz, kPa.s/L -0.16 [-0.23; -0.11]
Xrs5Hz, % predicted 166 [106; 190]
∆Rrs5Hz-20Hz, kPa.s/L 0.15 [0.10; 0.21]
∆Rrs5Hz-20Hz, % predicted 213 [165; 296]
AX, Hz.kPa.s/L 1.41 [0.91; 1.97]
AX, % predicted 363 [268; 514]
Bronchodilator response
FEV1, % increase +8 [+1; +12]
FVC, % increase +6 [+1; +12]
IC, % increase +12 [+3; +22]
Zrs5Hz, % decrease 0 [-9; +12]
Rrs5Hz, % decrease +12 [-3; +21]
Xrs5Hz, (post-pre) 0.03 [0.01; 0.07]
∆Rrs5Hz-20Hz, % decrease +25 [+10; +33]
AX, % decrease +32 [+17; +47]